Ulrike Maria Margarethe Bauer

Ulrike Maria Margarethe Bauer

Auto-generated profile, based on publicly available information

Ulrike Maria Margarethe Bauer

National Register for Congenital Heart Defects, 13353 Berlin, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2015 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
PHPaul C. Helm
Paul C. Helm
MKMarc-André Koerten
Marc-André Koerten
HAHashim Abdul-Khaliq
Hashim Abdul-Khaliq
HBHelmut Baumgartner
Helmut Baumgartner
DKDeniz Kececioglu
Deniz Kececioglu
UBUlrike M. M. Bauer
Ulrike M. M. Bauer
Background: Approximately 6000 children are born with CHD in Germany each year. It is increasingly rare that these children die from their chronic illness. In the present study, data recorded in the National Register for Congenital Heart Defects with respect to the prevalence of specific lesions and sex distribution are compared with that recorded in a published German prevalence study (Prevalence Study) and with the meta-analysis by van der Linde et al.Methods: A descriptive data analysis was performed using a minimal data set. The demographic data included sex and birth year; the medical data comprised the cardiovascular diagnosis according to the short list of the International Paediatric and Congenital Cardiac Code.Results: As the data analysis shows, the National Register is a clinical register including primarily clinical cases/cases relevant to healthcare. The prevalence values and sex ratios recorded in the register are closer to the values given in the literature than those determined by the Prevalence Study. Severe CHD was slightly over-represented in the National Register compared with the van der Linde et al meta-analysis. The deviations with respect to prevalence values are within an acceptable range.Conclusion: With its 48,000 patients, the National Register plays a unique and important role for research in the field of CHD. Samples from the National Register can be used as a gold standard for future studies, as the patient population registered in it can be considered representative of CHD in Germany and Europe.

21 January 2022 in Circulation Research
Verified
Journal Article
Open access
PDF file
DŠDoris Škorić-Milosavljević
Doris Škorić-Milosavljević
RTRafik Tadros
Rafik Tadros
FBFernanda M. Bosada
Fernanda M. Bosada
FTFederico Tessadori
Federico Tessadori
JWJan Hendrik van Weerd
Jan Hendrik van Weerd
CBConnie Bezzina
Connie Bezzina
Rationale: Dextro-transposition of the great arteries (D-TGA) is a severe congenital heart defect which affects approximately 1 in 4,000 live births. While there are several reports of D-TGA patients with rare variants in individual genes, the majority of D-TGA cases remain genetically elusive. Familial recurrence patterns and the observation that most cases with D-TGA are sporadic suggest a polygenic inheritance for the disorder, yet this remains unexplored. Objective: We sought to study the role of common single nucleotide polymorphisms (SNPs) in risk for D-TGA. Methods and Results: We conducted a genome-wide association study in an international set of 1,237 patients with D-TGA and identified a genome-wide significant susceptibility locus on chromosome 3p14.3, which was subsequently replicated in an independent case-control set (rs56219800, meta-analysis P=8.6x10 -10 , OR=0.69 per C allele). SNP-based heritability analysis showed that 25% of variance in susceptibility to D-TGA may be explained by common variants. A genome-wide polygenic risk score derived from the discovery set was significantly associated to D-TGA in the replication set (P=4x10 -5 ). The genome-wide significant locus (3p14.3) co-localizes with a putative regulatory element that interacts with the promoter of WNT5A , which encodes the Wnt Family Member 5A protein known for its role in cardiac development in mice. We show that this element drives reporter gene activity in the developing heart of mice and zebrafish and is bound by the developmental transcription factor TBX20. We further demonstrate that TBX20 attenuates Wnt5a expression levels in the developing mouse heart. Conclusions: This work provides support for a polygenic architecture in D-TGA and identifies a susceptibility locus on chromosome 3p14.3 near WNT5A . Genomic and functional data support a causal role of WNT5A at the locus.

16 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSusanne J. Maurer
Susanne J. Maurer
UBUlrike M. M. Bauer
Ulrike M. M. Bauer
HBHelmut Baumgartner
Helmut Baumgartner
AUAnselm Uebing
Anselm Uebing
CWClaudia Walther
Claudia Walther
OTOktay Tutarel
Oktay Tutarel
Background: As adults with congenital heart disease (ACHD) are getting older, acquired comorbidities play an important role in morbidity and mortality. Data regarding their prevalence in ACHD that are representative on a population level are not available. Methods: The German National Register for Congenital Heart Defects was screened for ACHD. Underlying congenital heart disease (CHD), patient demographics, previous interventional/surgical interventions, and comorbidities were retrieved. Patients <40 years of age were compared to those ≥40 years. Results: A total of 4673 patients (mean age 33.6 ± 10.7 years, female 47.7%) was included. At least one comorbidity was present in 2882 patients (61.7%) altogether, and in 56.8% of patients below vs. 77.7% of patients over 40 years of age (p < 0.001). Number of comorbidities was higher in patients ≥40 years (2.1 ± 2.1) than in patients <40 years (1.2 ± 1.5, p < 0.001). On multivariable regression analysis, age and CHD complexity were significantly associated with the presence and number of comorbidities. Conclusions: At least one acquired comorbidity is present in approximately two-thirds of ACHD. Age and complexity of the CHD are significantly associated with the presence of comorbidities. These findings highlight the importance of addressing comorbidities in ACHD care to achieve optimal long-term outcomes.

Verified
Journal Article
Open access
PDF file
LSLavinia Seidel
Lavinia Seidel
KNKathrin Nebel
Kathrin Nebel
SAStephan Achenbach
Stephan Achenbach
UBUlrike Bauer
Ulrike Bauer
PEPeter Ewert
Peter Ewert
RNRhoia C. Neidenbach
Rhoia C. Neidenbach
Background: Due to the increase in survival rates for congenital heart disease (CHD) in the last decades, over 90% of patients today reach adulthood. Currently, there are more than 300,000 adults with CHD (ACHD) living in Germany. They have an increased need for specialized medical care, since almost all ACHD have chronic heart disease and suffer from specific chronic symptoms, risks, and sequelae. Primary care physicians (PCPs) play a crucial role in referring patients to ACHD specialists or specialized institutions. This cross-sectional study is intended to clarify the real-world care of ACHD from the PCP’s perspective. Methods: This analysis, initiated by the German Heart Centre Munich, was based on a 27-item questionnaire on actual ACHD health care practice in Germany from the PCP’s perspective. Results: In total, 767 questionnaires were considered valid for inclusion. The majority of the PCPs were general practitioners (95.9%), and 84.1% had cared for ACHD during the past year. A majority (69.2%) of the PCPs had cared for patients with simple CHD, while 50.6% and 33.4% had cared for patients with moderate and severe CHD, respectively, in all age groups. PCPs treated almost all typical residual symptoms and sequelae, and advised patients regarding difficult questions, including exercise capacity, pregnancy, genetics, and insurance matters. However, 33.8% of the PCPs did not even know about the existence of certified ACHD specialists or centers. Only 23.9% involved an ACHD-specialized physician in their treatment. In cases of severe cardiac issues, 70.8% of the PCPs referred patients to ACHD-certified centers. Although 52.5% of the PCPs were not sufficiently informed about existing structures, 64.2% rated the current care situation as either “very good” or “good”. Only 26.3% (n = 190) of the responding physicians were aware of patient organizations for ACHD. Conclusions: The present study showed that the majority of PCPs are not informed about the ACHD care structures available in Germany. The need for specialized ACHD follow-up care is largely underestimated, with an urgent need for optimization to reduce morbidity and mortality. For the future, solutions must be developed to integrate PCPs more intensively into the ACHD care network.

1 December 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
AFAnn-Katrin Flügge
Ann-Katrin Flügge
KWKristina Wasmer
Kristina Wasmer
SOStefan Orwat
Stefan Orwat
HAHashim Abdul-Khaliq
Hashim Abdul-Khaliq
PHPaul C. Helm
Paul C. Helm
GDGerhard-Paul Diller
Gerhard-Paul Diller

1 April 2000 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
Michael BauerMichael Bauer
Michael Bauer
VAV. Alexi-Meskishvilli
V. Alexi-Meskishvilli
Zoran NakićZoran Nakić
Zoran Nakić
SRS. Redzepagic
S. Redzepagic
UBU. Bauer
U. Bauer
RHR. Hetzer
R. Hetzer
Background: The minimally and less invasive approaches for the surgical treatment of different heart diseases are rapidly increasing because of their cosmetic and recovery-related advantages. Presented here are the results of less invasive surgery in 51 patients with congenital heart defects. Methods: From June 1996 to January 1999, we used less invasive techniques for the correction of congenital heart defects in 51 patients. In 32 patients, we performed right anterolateral thoracotomy (6 - 13 cm), and on the other 19 patients, we used the partial inferior sternotomy (4 - 7 cm). The ascending aorta and the caval veins were cannulated in all patients. Results: The following congenital heart defects were corrected: ostium secundum atrial septal defect (n = 35), sinus venosus atrial septal defect with partial anomalous pulmonary venous connection (n = 7), ventricular septal defect (n = 7), tetralogy of Fallot (n = 1), and cor triatriatum sinistrum (n = 1). The average age of the patients was 15 years old ranging from 2 months to 48 years and the average weight 39.6 kg (range 3.8 - 86 kg). The patients were removed from artificial respiratory support on average 8 hours (range 1 - 48 hours) after surgery and left the hospital after 7 days (range 2 - 10 days). In 16 patients, blood transfusions were required, an average 5.7 ml/kg BW (range 1.45 - 19.75 ml/kg BW). The postoperative course was uneventful in all patients. Follow-up (range 3 - 33 months, mean 17.5 months) was complete with no late deaths or residual defects. Conclusion: The right anterolateral thoracotomy and the partial inferior sternotomy provide a safe approach for the correction of certain congenital heart defects. These techniques enable operative correction without any additional risks being incurred and can be performed with standard instruments and cannulation. Additional approaches for extracorporeal circulation are unnecessary.